LXEO Lexeo Therapeutics, Inc.

Fundamentals / CIK 0001907108 / USD

Lexeo Therapeutics, Inc. reported $243.9M in total assets and a net loss of $105.3M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open LXEO in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

4 fiscal years (2022 to 2025), reported in USD.

$11.20M$5.60M$0-$93.56MFY 2022 Revenue: $654KFY 2022 Net Income: -$59.28M2022FY 2023 Net Income: -$66.39M2023FY 2024 Net Income: -$98.33M2024FY 2025 Net Income: -$100.0M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31
Revenue -- -- -- $654K
Research & Development $63.80M $74.09M $53.13M $49.16M
Total Operating Expenses $109.3M $105.8M $68.51M $61.16M
Operating Income -$109.3M -$105.8M -$68.51M -$60.51M
EBITDA -$109.0M -$105.5M -$68.24M -$60.39M
Interest Income $6.13M $7.56M $2.87M $1.32M
Interest Expense $95K $137K $205K $91K
Income Before Tax -$99.67M -$98.44M -$66.39M -$59.28M
Income Tax Expense $0 $0 -- --
Net Income -$100.0M -$98.33M -$66.39M -$59.28M
Basic EPS -$1.86 -$3.09 -$12.40 -$36.36
Diluted EPS -$1.86 -$3.09 -$12.40 -$36.36
Basic Shares Outstanding 53.6M 31.8M 5.4M 1.6M
Diluted Shares Outstanding 53.6M 31.8M 5.4M 1.6M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $34.50M $19.03M $15.70M $16.21M $15.70M $14.72M $17.17M $18.37M
Total Operating Expenses $40.40M $28.02M $22.33M $23.12M $21.65M $30.69M $33.80M $27.38M
Operating Income -$40.40M -$28.02M -$22.33M -$23.12M -$21.65M -$30.69M -$33.80M -$27.38M
EBITDA -$40.31M -$27.95M -$22.26M -$23.04M -$21.57M -$30.63M -$33.74M -$27.31M
Interest Income $2.16M $2.19M $2.11M $2.21M $1.46M $1.27M $1.19M $1.47M
Interest Expense $12K $14K $17K $20K $22K $25K $28K $30K
Income Before Tax -$38.30M -$25.87M -$20.20M -$20.63M -$20.28M -$26.10M -$32.66M -$26.03M
Net Income -$38.30M -$25.87M -$20.20M -$20.96M -$20.28M -$26.10M -$32.66M -$25.92M
Basic EPS -$0.43 -$0.30 -$0.25 -- -$0.33 -$0.60 -$0.99 --
Diluted EPS -$0.43 -$0.30 -$0.25 -- -$0.33 -$0.60 -$0.99 --
Basic Shares Outstanding 88.7M 85.6M 81.2M -- 61.0M 43.6M 33.1M --
Diluted Shares Outstanding 88.7M 85.6M 81.2M -- 61.0M 43.6M 33.1M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $63.00M $35.01M $121.5M $77.33M
Short-Term Investments $118.8M $86.50M -- --
Cash & Short-Term Investments $181.8M $128.5M $121.5M $77.33M
Other Current Assets -- -- $3.0K $371K
Total Current Assets $188.4M $126.1M $124.3M $80.05M
Property, Plant & Equipment, Net $1.14M $1.03M $1.06M $998K
Long-Term Investments $64.80M $7.01M -- --
Total Non-Current Assets $80.30M $20.82M $15.51M $17.03M
Total Assets $268.7M $146.9M $139.8M $97.08M
Accounts Payable $4.86M $6.42M $3.79M $2.68M
Total Current Liabilities $16.81M $22.85M $17.24M $14.35M
Total Non-Current Liabilities $5.21M $7.25M $9.03M $10.65M
Total Liabilities $22.02M $30.10M $26.27M $25.00M
Total Debt (incl. Leases) $7.89M $9.92M $11.64M $13.48M
Common Stock $7.0K $3.0K $3.0K $0
Retained Earnings -$380.1M -$280.2M -$181.8M -$115.4M
Accumulated Other Comp. Income $188K -$103K -- --
Total Stockholders' Equity $246.7M $116.8M $113.5M -$113.0M
Total Equity $246.7M $116.8M $113.5M -$113.0M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $90.22M $92.83M $71.77M $63.00M $41.00M $35.48M $28.91M $35.01M
Short-Term Investments $104.6M $118.9M $121.3M $118.8M $81.77M $97.41M $70.92M $86.50M
Cash & Short-Term Investments $219.1M $234.2M $227.6M $181.8M $122.8M $132.9M $106.9M $128.5M
Total Current Assets $204.9M $217.9M $200.9M $188.4M $127.8M $140.1M $105.3M $126.1M
Property, Plant & Equipment, Net $1.73M $1.12M $1.10M $1.14M $1.23M $1.11M $1.04M $1.03M
Long-Term Investments $24.35M $22.47M $34.51M $64.80M $0 $19.61M $7.04M $7.01M
Total Non-Current Assets $38.99M $36.99M $49.49M $80.30M $16.05M $36.01M $20.42M $20.82M
Total Assets $243.9M $254.9M $250.4M $268.7M $143.8M $176.1M $125.7M $146.9M
Accounts Payable $3.69M $4.18M $3.33M $4.86M $4.66M $20.02M $11.98M $6.42M
Total Current Liabilities $23.59M $15.69M $14.19M $16.81M $17.27M $31.59M $30.82M $22.85M
Total Non-Current Liabilities $3.64M $4.14M $4.67M $5.21M $5.74M $6.26M $6.75M $7.25M
Total Liabilities $27.23M $19.84M $18.86M $22.02M $23.01M $37.85M $37.58M $30.10M
Total Debt (incl. Leases) $6.25M $6.81M $7.37M $7.89M $8.46M $8.91M $9.40M $9.92M
Common Stock $8.0K $8.0K $7.0K $7.0K $5.0K $5.0K $3.0K $3.0K
Retained Earnings -$464.5M -$426.2M -$400.3M -$380.1M -$359.2M -$338.9M -$312.8M -$280.2M
Accumulated Other Comp. Income -$465K -$298K -$142K $188K $89K -$13K -$54K -$103K
Total Stockholders' Equity $216.7M $235.1M $231.5M $246.7M $120.8M $138.2M $88.11M $116.8M
Total Equity $216.7M $235.1M $231.5M $246.7M $120.8M $138.2M $88.11M $116.8M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$99.96M -$98.33M -$66.39M -$59.28M
Depreciation & Amortization $268K $304K $271K $120K
Stock-Based Compensation $12.13M $12.47M $3.04M $1.78M
Change in Payables -$1.56M $2.38M -$180K -$426K
Operating Cash Flow -$98.56M -$81.15M -$59.50M -$54.56M
Capital Expenditure -$397K -$481K -$115K -$672K
Free Cash Flow -$98.96M -$81.63M -$59.61M -$55.23M
Purchases of Investments -$195.4M -$93.60M -- --
Sales & Maturities of Investments $105.5M -- -- --
Investing Cash Flow -$90.25M -$94.08M -$165K -$901K
Common Stock Issued $270K -- -- --
Financing Cash Flow $216.8M $88.78M $103.8M $189K
Net Change in Cash $27.98M -$86.45M $44.13M -$55.27M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$38.30M -$25.87M -$20.20M -$20.92M -$20.28M -$26.10M -$32.66M -$25.92M
Depreciation & Amortization $86K $74K $73K $73K $73K $62K $60K $75K
Stock-Based Compensation $3.69M $5.69M $2.75M $2.71M $2.65M $3.07M $3.70M $3.51M
Change in Payables -$883K $828K -$1.60M $200K -$15.27M $8.36M $5.14M -$2.04M
Operating Cash Flow -$28.56M -$17.60M -$21.14M -$20.08M -$29.55M -$27.22M -$21.72M -$28.33M
Capital Expenditure -$298K -$7.0K -$35K -- -- -- -- $0
Free Cash Flow -$28.86M -$17.60M -$21.18M -- -- -- -- -$28.33M
Sales & Maturities of Investments $32.20M $26.24M $27.50M $38.33M $35.30M $16.30M $15.60M --
Investing Cash Flow $11.92M $14.26M $27.46M -$101.7M $35.01M -$39.17M $15.60M -$93.58M
Common Stock Issued $14.61M $24.86M $143K $270K $0 -$170K $170K --
Financing Cash Flow $14.03M $24.40M $2.45M $143.8M $52K $72.96M $11K -$97K
Net Change in Cash -$2.62M $21.07M $8.77M $22.00M $5.52M $6.57M -$6.11M -$122.0M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -- -- -- -9252.1%
Net Profit Margin -- -- -- -9063.8%
Return on Equity (ROE) -40.5% -84.2% -58.5% --
Return on Assets (ROA) -37.2% -66.9% -47.5% -61.1%
Current Ratio 11.21x 5.52x 7.21x 5.58x
Quick Ratio 10.81x 5.62x 7.05x 5.39x
Debt to Equity 0.03x 0.08x 0.10x --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -48.6% -37.1% -37.8% -40.5% -86.9% -82.6% -124.1% -84.2%
Return on Assets (ROA) -43.2% -34.3% -35.0% -37.2% -73.0% -64.8% -87.0% -66.9%
Current Ratio 8.69x 13.89x 14.16x 11.21x 7.40x 4.43x 3.42x 5.52x
Quick Ratio 9.29x 14.92x 16.04x 10.81x 7.11x 4.21x 3.47x 5.62x
Debt to Equity 0.03x 0.03x 0.03x 0.03x 0.07x 0.06x 0.11x 0.08x
Source: SEC EDGAR CompanyFacts (CIK 0001907108) · from March 31, 2022 Data through September 30, 2026 · synced Nov 20, 2026, 05:42 UTC · Open in terminal